|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Fixed maturity available-for-sale securities | ||||||||||||||||||||
| Fixed maturity AFS securities | ||||||||||||||||||||
| Total Fixed maturity available-for-sale securities | ||||||||||||||||||||
| Equity available-for-sale securities, at estimated fair value (cost: 2018 - $0; 2017 - $25,473) | ||||||||||||||||||||
| Equity securities, at estimated fair value (cost: 2018 - $25,473; 2017 - $0) | ||||||||||||||||||||
| Limited partnerships | ||||||||||||||||||||
| Mortgage loans on real estate | ||||||||||||||||||||
| Policy loans | ||||||||||||||||||||
| Derivative assets | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Deferred sales inducements | ||||||||||||||||||||
| Value of business acquired | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Income tax asset | ||||||||||||||||||||
| Reinsurance receivables | ||||||||||||||||||||
| Affiliated receivable - net | ||||||||||||||||||||
| Affiliated short-term note receivable | ||||||||||||||||||||
| Receivable for investments sold - net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Recoverable of ceded guaranteed minimum income benefit embedded derivatives, at fair value | ||||||||||||||||||||
| Separate Accounts assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDER’S EQUITY | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Policyholder liabilities and accruals | ||||||||||||||||||||
| Policyholder account balances | ||||||||||||||||||||
| Future policy benefits | ||||||||||||||||||||
| Claims and claims settlement expenses | ||||||||||||||||||||
| Total policyholder liabilities and accruals | ||||||||||||||||||||
| Payables for collateral under securities loaned, reverse repurchase agreements and derivatives | ||||||||||||||||||||
| Checks not yet presented for payment | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Income tax liability | ||||||||||||||||||||
| Affiliated payables - net | ||||||||||||||||||||
| Affiliated short-term note payable | ||||||||||||||||||||
| Reinsurance payables | ||||||||||||||||||||
| Payable for investments purchased - net | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Dividend payable to Transamerica Corporation | ||||||||||||||||||||
| Separate Accounts liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholder’s Equity | ||||||||||||||||||||
| Common stock ($10 par value; authorized 1,000,000 shares; issued and outstanding: 250,000 shares) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income, net of taxes | ||||||||||||||||||||
| Retained Earnings (Deficit) | ||||||||||||||||||||
| Total Stockholder’s Equity | ||||||||||||||||||||
| Total Liabilities and Stockholder’s Equity | ||||||||||||||||||||
Loading...
